Alitretinoin. Retinoid treatment of chronic hand dermatitis

Drugs of the Future

Volumn 32, Issue 11, 2007, Pages 943-951

  Scheinfeld, Noah ^a   Michaels, Jason ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; PLACEBO; RETINOIC ACID RECEPTOR; RETINOID BINDING PROTEIN; RETINOID X RECEPTOR;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG BINDING; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG RESPONSE; DRUG SYNTHESIS; DRUG TOLERANCE; ECZEMA; FEMALE; FLUSHING; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KAPOSI SARCOMA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THYROXIN BLOOD LEVEL;

EID: 38649084422     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2007.032.11.1149766     Document Type: Article

References (29)

1. Coe, J.W. (Pfizer, Inc.). Method for the preparation of 9-cis retinoic acid. WO 9422818.
2. Coe, J.W., O'Connell, T. Convenient preparation of 9-cis-retinoic acid. Bioorg Med Chem Lett 1994, 4(2): 349-50.
3. 3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem 1994, 37(3): 408-14.
4. Bennani, Y.L. An efficient and stereoselective synthesis of 9-cis-retinoic acid. J Org Chem 1996, 61(10): 3542-4.
5. Wada, A., Hiraishi, S., Takamura, N., Date, T., Aoe, K., Ito, M. A novel method for a stereoselective synthesis of trisubstituted olefin using tricarbonyliron complex: A highly stereoselective synthesis of (all-E)- and (9Z)-retinoic acids. J Org Chem 1997, 62(13): 4343-8.
6. Wada, A., Fukunaga, K., Ito, M., Mizuguchi, Y., Nakagawa, K., Okano, T. Preparation and biological activity of 13-substituted retinoic acids. Bioorg Med Chem 2004, 12(14): 3931-42.
7. Pazos, Y., de Lera, A.R. Stereoselective synthesis of 9-cis-retinoic acid by Suzuki reaction. Tetrahedron Lett 1999, 40(47): 8287-90.
8. Pazos, Y., Iglesias, B., de Lera, A.R. The Suzuki coupling reaction in the stereocontrolled synthesis of 9-cis-retinoic acid and its ring-demethylated analogues. J Org Chem 2001, 66(25): 8483-9.
9. 2-9-cis-retinoic acid. J Org Chem 1995, 60(5): 1195-200.
10. 3C]-9-cis-retinoic acid with high specific activity. J Label Comp Radiopharm 1997, 34(1): 1-10.
11. DeLuca, H.F., Tadikonda, P.K. (Wisconsin Alumni Res. Found.). Method of synthesis of retinoic acid. US 5808120.
12. John, M., Paust, J. (BASF AG). Preparation of 9-(Z)-retinoic acid. US 5504230.
13. Soukup, M., Thomessen, R. (F. Hoffmann-la Roche AG). Process for the production of 9-cis retinoic acid. CA 2520018, EP 1615879, JP 2006522757, US 2004235951, US 7015353, WO 2004089887.
14. Robeson, C.D., Cawley, J.D., Weisler, L., Stern, M.H., Eddinger, C.C., Chechak, A.J. Chemistry of vitamin A. XXIV. The synthesis of geometric isomers of vitamin A via methyl beta-methylglutaconate. J Am Chem Soc 1955, 77(15): 4111.
15. de Lera, A.R., Castro, A., Torrado, A., Lopez, S. Stereo-selective isomerization of 10-arylsulfenate-11,12-dehydroretinoids to 9-cis-retinoids. Tetrahedron Lett 1998, 39(25): 4575-8.
16. von Isler, O., Huber, W., Ronco, A., Kofler, M. Synthese des vitamin A. Helv Chim Acta 1947, 30(6): 1911-27.
17. Marshall, J.A., Tang, Y. Enantioselective synthesis of carbohydrate precursors via 1,2:2,3-bis-epoxide intermediates. J Org Chem 1994, 59(6): 1457-64.
18. Lopez, S., Rodriguez, J., Rey, J.G., de Lera, A.R. Structural effects affecting the thermal electrocyclic ring closure of vinylallenes to alkylidenecyclobutenes. J Am Chem Soc 1996, 18(8): 1881-91.
19. Cheer, S.M., Foster, R.H. Alitretinoin. Am J Clin Dermatol 2000, 1(5): 307-14; discussion 315-6.
20. Allenby, G., Bocquel, M.T., Saunders, M. et al. Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 1993, 90(1): 30-4.
21. Miller, W.H. Jr., Jakubowski, A., Tong, W.P. et al. 9-cis Retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukaemia. Blood 1995, 85(11): 3021-7.
22. Duvic, M., Friedman-Kien, A.E., Looney, D.J. et al. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: Results of phase 1 and 2 trials. Arch Dermatol 2000, 136(12): 1461-9.
23. Gottardis, M.M., Lamph, W.W., Shalinsky, D.R., Wellstein, A., Heyman, R.A. The efficacy of 9-cis retinoic acid in experimental models of cancer. Breast Cancer Res Treat 1996, 38(1): 85-96.
24. Adamson, P.C., Godwin, K.A., Murphy, R.F., Ulm, E.H., Balis, F.M. Pharmacokinetics (PK) of 9-cis retinoic acid (9-cis RA) following intravenous administration in the rhesus monkey. Proc Am Assoc Cancer Res (AACR) 1994, 35: Abst 2554.
25. Adamson, P.C., Murphy, R.F., Godwin, K.A., Ulm, E.H., Balis, F.M. Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey. Cancer Res 1995, 55(3): 482-5.
26. Bollag, W., Ott, F. Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid. Dermatology 1999, 199(4): 308-12.
27. Ruzicka, T., Larsen, F.G., Galewicz, D. et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: Results of a randomised, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004, 140(12): 1453-9.
28. Ruzicka, T., Gupta, A., Jemec, G., Gerlach, B., Maares, J., Wevelsiep, L. Efficacy and safety of alitretinoin in severe refractory chronic hand dermatitis. 16th Congr Eur Acad Dermatol Venereol (EADV) (May 16-20, Vienna) 2007, Abst P275.
29. European health authorities accept marketing authorization application for alitretinoin. DailyDrugNews.com, October 15, 2007.